Unity Biotechnology Inc.

Unity Biotechnology Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. Unity Biotechnology Inc. is not a good value stock. Unity Biotechnology Inc. is a mediocre stock to choose.
Log in to see more information.
Unity Biotechnology, Inc. operates as a biotechnology company engaged in the research and developmen...
UBX Fundamental Data by TradingView

News

Unity Biotechnology (NASDAQ:UBX) Now Covered by Analysts at Rodman & Renshaw
Unity Biotechnology (NASDAQ:UBX) Now Covered by Analysts at Rodman & Renshaw

Ticker Report Rodman Renshaw assumed coverage on shares of Unity Biotechnology (NASDAQ:UBX - Free Report) in a research note released on Thursday, Marketbeat Ratings reports. The firm issued a buy rating...\n more…

Unity Biotechnology initiated with bullish view at Rodman & Renshaw
Unity Biotechnology initiated with bullish view at Rodman & Renshaw

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

UNITY Biotechnology to Participate in Upcoming Investor Conferences
UNITY Biotechnology to Participate in Upcoming Investor Conferences

Globe Newswire SAN FRANCISCO, Aug. 12, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. ( UNITY ) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of aging, today...\n more…

FY2028 EPS Estimates for Unity Biotechnology, Inc. Raised by HC Wainwright (NASDAQ:UBX)
FY2028 EPS Estimates for Unity Biotechnology, Inc. Raised by HC Wainwright (NASDAQ:UBX)

Ticker Report Unity Biotechnology, Inc. (NASDAQ:UBX - Free Report) - Stock analysts at HC Wainwright boosted their FY2028 earnings per share estimates for shares of Unity Biotechnology in a research note issued to...\n more…

Q3 2024 EPS Estimates for Unity Biotechnology, Inc. (NASDAQ:UBX) Boosted by HC Wainwright
Q3 2024 EPS Estimates for Unity Biotechnology, Inc. (NASDAQ:UBX) Boosted by HC Wainwright

Zolmax Unity Biotechnology, Inc. (NASDAQ:UBX - Free Report) - HC Wainwright raised their Q3 2024 earnings per share (EPS) estimates for shares of Unity Biotechnology in a research note issued to investors...\n more…

UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know
UNITY Biotechnology (UBX) Upgraded to Buy: Here's What You Should Know

Zacks Investment Research Investors might want to bet on UNITY Biotechnology, Inc. (UBX), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in earnings estimates -- one of the most powerful forces...\n more…